Mr. Golub has served as Chairman of our Board of Directors since November 2009. He is also the Chief Executive Officer of Golub Capital and serves on the Investment Committee of our investment adviser, GC Advisors LLC.
Mr. Golub is active in charitable and civic organizations. He is one of two private members of the Financial Control Board of the State of New York, a member of the Harvard Medical School Board of Fellows, a member of the Columbia Medical School Board of Advisors, President of the Harvard University JD-MBA Alumni Association, a member of the Advisory Council of Harvard Kennedy School’s Mossavar-Rahmani Center for Business & Government and a trustee of the American Repertory Theater. Mr. Golub and his family actively support medical research to advance treatments for Parkinson’s disease at several leading institutions, including serving on the Leadership Council of the New York Stem Cell Foundation.
Previously, Mr. Golub was a Managing Director of Bankers Trust Company. Prior to that, he was a Managing Director of Wasserstein Perella where he established the firm’s capital markets group and debt restructuring practice. Mr. Golub started his career at Allen & Company Incorporated where he engaged in private equity, leveraged finance and mergers and acquisitions.
Mr. Golub was a White House Fellow and served for fifteen years as Treasurer of the White House Fellows Foundation. He was Chairman of Mosholu Preservation Corporation, a non-profit developer and manager of low-income housing in the Bronx. He served for fifteen years as a trustee of Montefiore Medical Center, the university hospital of the Albert Einstein Medical School. He also served for six years as a trustee of Horace Mann School and for five years on the Harvard University Committee for Science and Engineering.
Mr. Golub earned his AB degree magna cum laude in economics from Harvard College. He received an MBA from Harvard Business School, where he was selected as a Baker Scholar, and a JD from Harvard Law School, where he served as an editor of the Harvard Law Review.